CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Using an index divisor in calculations helps maintain consistent measurements when prices or shares change, enabling fair comparisons.
22,619 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Pi Network’s PI token fell about 5% after Pi2Day hype, even as Bitcoin moved back to the $60,000 level. The market re...
A Dutch court halted a welfare-detection AI system over privacy and bias concerns, prompting watchdogs to weigh tight...
South Korea's grief-tech niche is moving from curiosity to commerce, with AI-generated memorial videos averaging near...
Oil traffic through the Hormuz Strait shows signs of stabilization, with several tankers choosing an Oman-side route ...
ANSEM surged 299% over the past week, reviving momentum in Solana's memecoin scene and lifting overall ecosystem acti...
Oil trades around $79 per barrel as markets digest supply discipline and demand signals. The current price july 2026 ...
As of mid-July 2026, XRP navigates a choppy crypto landscape. AI-driven ripple price predictions: asked assessments p...
A real-world look at how a name, forged document, and a $2,500 scam can ripple through personal finances. Learn how t...
Federal health officials tie lettuce from mexico sold to Taco Bell and other outlets to a cyclospora outbreak spannin...
A Capitol Hill hearing put Meta under sharp scrutiny over its teen and tween targeting. Lawmakers demanded tighter sa...
A landmark ruling reshapes trade policy and could alter stock market dynamics. This guide breaks down what happened, ...